Funded Tech Companies
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biopharmaceutical growth company, located in Cambridge. Venture capital investment was provided by Forbion Capital Partners, Omega Funds and Atlas Venture.
Company Overview
Company Name
Rectify Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Rectify is developing Positive Functional Modulators (PFMs), disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/18/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rajesh Devraj
Chief Operating Officer
Tracey Dawson
Chief Scientific Officer
Jonathan Moore
Vice President
Alastair Garfield
Vice President
Janeta Popovici-Muller
Company Investors
- Forbion Capital Partners (Marco Boorsma)
- Omega Funds (Otello Stampacchia)
- Atlas Venture (Jason Rhodes)
- Longwood Fund (David Steinberg)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs